Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance
- Clare C. Walsh
- , Cornelia B. Landersdorfer
- , Michelle P. McIntosh
- , Anton Y. Peleg
- , Elizabeth B. Hirsch
- , Carl M. Kirkpatrick
- , Phillip J. Bergen
Research output: Contribution to journal › Article › peer-review
38
Link opens in a new tab
Scopus
citations